# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-029687
Filing Date
2023-03-08
Accepted
2023-03-07 19:00:17
Documents
78
Period of Report
2023-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm238578d1_8k.htm iXBRL | 8-K | 137837
2 | EXHIBIT 3.1 | tm238578d1_ex3-1.htm | EX-3.1 | 53568
3 | EXHIBIT 3.2 | tm238578d1_ex3-2.htm | EX-3.2 | 137028
4 | EXHIBIT 10.4 | tm238578d1_ex10-4.htm | EX-10.4 | 143042
5 | EXHIBIT 10.5 | tm238578d1_ex10-5.htm | EX-10.5 | 133034
6 | EXHIBIT 10.6 | tm238578d1_ex10-6.htm | EX-10.6 | 105003
7 | EXHIBIT 10.7 | tm238578d1_ex10-7.htm | EX-10.7 | 125499
8 | EXHIBIT 10.8 | tm238578d1_ex10-8.htm | EX-10.8 | 160939
9 | EXHIBIT 10.9 | tm238578d1_ex10-9.htm | EX-10.9 | 120743
10 | EXHIBIT 10.10 | tm238578d1_ex10-10.htm | EX-10.10 | 139503
11 | EXHIBIT 10.11 | tm238578d1_ex10-11.htm | EX-10.11 | 56082
12 | EXHIBIT 10.12 | tm238578d1_ex10-12.htm | EX-10.12 | 59845
13 | EXHIBIT 10.13 | tm238578d1_ex10-13.htm | EX-10.13 | 75361
14 | EXHIBIT 10.14 | tm238578d1_ex10-14.htm | EX-10.14 | 33638
15 | EXHIBIT 10.15 | tm238578d1_ex10-15.htm | EX-10.15 | 37084
16 | EXHIBIT 10.16 | tm238578d1_ex10-16.htm | EX-10.16 | 42015
17 | EXHIBIT 14.1 | tm238578d1_ex14-1.htm | EX-14.1 | 44311
18 | EXHIBIT 16.1 | tm238578d1_ex16-1.htm | EX-16.1 | 2242
19 | EXHIBIT 99.1 | tm238578d1_ex99-1.htm | EX-99.1 | 14887
20 | EXHIBIT 99.2 | tm238578d1_ex99-2.htm | EX-99.2 | 377541
21 | EXHIBIT 99.3 | tm238578d1_ex99-3.htm | EX-99.3 | 523975
26 | GRAPHIC | tm238578d1_ex99-2img001.jpg | GRAPHIC | 44178
27 | GRAPHIC | tm238578d1_ex99-2img01.jpg | GRAPHIC | 31363
28 | GRAPHIC | tm238578d1_ex99-2img02.jpg | GRAPHIC | 40330
29 | GRAPHIC | tm238578d1_ex99-2img03.jpg | GRAPHIC | 75427
30 | GRAPHIC | tm238578d1_ex99-2img04.jpg | GRAPHIC | 26530
31 | GRAPHIC | tm238578d1_ex99-2img05.jpg | GRAPHIC | 28311
32 | GRAPHIC | tm238578d1_ex99-2img07.jpg | GRAPHIC | 69242
33 | GRAPHIC | tm238578d1_ex99-2img08.jpg | GRAPHIC | 44538
34 | GRAPHIC | tm238578d1_ex99-2img09.jpg | GRAPHIC | 36553
35 | GRAPHIC | tm238578d1_ex99-2img10.jpg | GRAPHIC | 33795
36 | GRAPHIC | tm238578d1_ex99-2img11.jpg | GRAPHIC | 10065
37 | GRAPHIC | tm238578d1_ex99-2img12.jpg | GRAPHIC | 49344
38 | GRAPHIC | tm238578d1_ex99-2img13.jpg | GRAPHIC | 36563
39 | GRAPHIC | tm238578d1_ex99-2img14.jpg | GRAPHIC | 32478
40 | GRAPHIC | tm238578d1_ex99-2img15.jpg | GRAPHIC | 22723
41 | GRAPHIC | tm238578d1_ex99-2img16.jpg | GRAPHIC | 38411
42 | GRAPHIC | tm238578d1_ex99-2img17.jpg | GRAPHIC | 14818
43 | GRAPHIC | tm238578d1_ex99-2img18.jpg | GRAPHIC | 36516
44 | GRAPHIC | tm238578d1_ex99-2img19.jpg | GRAPHIC | 29916
45 | GRAPHIC | tm238578d1_ex99-2img20.jpg | GRAPHIC | 49997
46 | GRAPHIC | tm238578d1_ex99-2img21.jpg | GRAPHIC | 17979
47 | GRAPHIC | tm238578d1_ex99-2img22.jpg | GRAPHIC | 67756
48 | GRAPHIC | tm238578d1_ex99-2img23.jpg | GRAPHIC | 33944
49 | GRAPHIC | tm238578d1_ex99-2img24.jpg | GRAPHIC | 19241
50 | GRAPHIC | tm238578d1_ex99-2img25.jpg | GRAPHIC | 46255
51 | GRAPHIC | tm238578d1_ex99-2img26.jpg | GRAPHIC | 40799
52 | GRAPHIC | tm238578d1_ex99-2img27.jpg | GRAPHIC | 28616
53 | GRAPHIC | tm238578d1_ex99-2img28.jpg | GRAPHIC | 39273
54 | GRAPHIC | tm238578d1_ex99-2img29.jpg | GRAPHIC | 32400
55 | GRAPHIC | tm238578d1_ex99-2img30.jpg | GRAPHIC | 24511
56 | GRAPHIC | tm238578d1_ex99-2img31.jpg | GRAPHIC | 33004
57 | GRAPHIC | tm238578d1_ex99-2img32.jpg | GRAPHIC | 38618
58 | GRAPHIC | tm238578d1_ex99-2img34.jpg | GRAPHIC | 19208
59 | GRAPHIC | tm238578d1_ex99-2img35.jpg | GRAPHIC | 26239
60 | GRAPHIC | tm238578d1_ex99-2img36.jpg | GRAPHIC | 41493
61 | GRAPHIC | tm238578d1_ex99-2img37.jpg | GRAPHIC | 19936
62 | GRAPHIC | tm238578d1_ex99-2img38.jpg | GRAPHIC | 17878
63 | GRAPHIC | tm238578d1_ex99-2img39.jpg | GRAPHIC | 25052
64 | GRAPHIC | tm238578d1_ex99-2img40.jpg | GRAPHIC | 23815
65 | GRAPHIC | tm238578d1_ex99-2img41.jpg | GRAPHIC | 23587
66 | GRAPHIC | tm238578d1_ex99-2img42.jpg | GRAPHIC | 25937
67 | GRAPHIC | tm238578d1_ex99-2img43.jpg | GRAPHIC | 22761
68 | GRAPHIC | tm238578d1_ex99-2img44.jpg | GRAPHIC | 40315
69 | GRAPHIC | tm238578d1_ex99-2img45.jpg | GRAPHIC | 27449
70 | GRAPHIC | tm238578d1_ex99-1img001.jpg | GRAPHIC | 3972
| Complete submission text file | 0001104659-23-029687.txt |  | 5410760

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
22 | XBRL TAXONOMY EXTENSION SCHEMA | carm-20230307.xsd | EX-101.SCH | 3274
23 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | carm-20230307_def.xml | EX-101.DEF | 26692
24 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | carm-20230307_lab.xml | EX-101.LAB | 36224
25 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | carm-20230307_pre.xml | EX-101.PRE | 25350
72 | EXTRACTED XBRL INSTANCE DOCUMENT | tm238578d1_8k_htm.xml | XML | 5115

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23714357
SIC: 2834 Pharmaceutical Preparations